Adaptimmune Ther Ads (NQ: ADAP )

5.940 USD +0.220 (+3.85%)

Official Closing Price Updated: 7:54 PM EST, Jan 19, 2021 Add to My Watchlist

Price and Volume

Volume	1,094,300
Open	5.840
Bid (Size)	5.850 (96)
Ask (Size)	6.000 (20)
Prev. Close	5.720
Today's Range	5.460 - 5.960
52wk Range	2.000 - 13.40
Shares Outstanding	94,143,326
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Adaptimmune to Showcase Market Potential for SPEAR T-cell Portfolio and Pipeline with Multiple Cell Therapy Platforms During Virtual Investor Day

November 20, 2020

Durable Responses with ADP-A2M4 in Synovial Sarcoma with Confirmed Responses in 44% of Patients and Disease Control Rate of 94% Presented at CTOS

November 19, 2020

Performance

YTD	-1.16%	-1.16%
1 Month	+20.00%	+20.00%
3 Month	+10.20%	+10.20%
6 Month	-37.87%	-37.87%
1 Year	+43.48%	+43.48%

More News

5 Best Penny Stocks To Buy Now According To Insiders

December 18, 2020

Adaptimmune to Host Virtual Investor Day on Friday, November 20th

November 12, 2020

Two Confirmed Responses and Five out of Six Patients with Initial Tumor Reductions from Early Dose Cohorts of SURPASS Trial, Presented at SITC

November 09, 2020

Adaptimmune Reports Q3 Financial Results and Business Update

November 05, 2020

Adaptimmune to Report Q3 Financial Results and Business Update on Thursday, November 5, 2020

October 22, 2020

First Week of ADAP February 19th Options Trading

January 11, 2021

First Week of January 2021 Options Trading For Adaptimmune Therapeutics (ADAP)

November 25, 2020

12 Healthcare Stocks Moving In Friday's Intraday Session

October 23, 2020

Adaptimmune Therapeutics is Now Oversold (ADAP)

October 21, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.